It is my understanding that when you do an interim

It is my understanding that when you do an interim analysis of the clinical trial results, the enrollment needs to stop until the analysis is over and the DSMB makes a decision on clinical trial direction. Please correct me if i am wrong but i believe that this is the protocol. Nader keeps saying they are enrolling but the numbers are stagnant. Please correct me!